Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 14, 2019
Patent Application Number
15618837
Date Filed
June 9, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The invention relates to the field of molecular medicine. In particular, it relates to compositions and methods to enhance the clearance of aberrant cells, e.g. cancer cells or virus-infected cells, by the host's immune system. Provided is a composition comprising (i) a therapeutic compound that can trigger a host's immune effector cells against an aberrant cell, such as a therapeutic antibody, and (ii) at least one agent capable of reducing or preventing inhibitory signal transduction initiated via SIRPalpha.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
